Metraipolis › archive › dc_6f9893c4e103

Effects of Gestational Arsenic Exposures on Placental and Fetal Development in Mice: The Role of Cyr61 m6A — Europe PMC PMID:37682722

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/37682722
DOI
10.1289/ehp12207
License (as archived)
CC0-1.0
Archived
2026-10-07T12:27:00.196Z
SHA-256 of the archived text
515447905c46270c25af1485a5cf527993fa90c48f1b81c900020f37122d20da
Stable URL of this page
https://metraipolis.com/documento/dc_6f9893c4e103

How to cite

Effects of Gestational Arsenic Exposures on Placental and Fetal Development in Mice: The Role of Cyr61 m6A — Europe PMC PMID:37682722 — Europe PMC (en), https://europepmc.org/article/MED/37682722 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_6f9893c4e103 (Metraipolis archive dc_6f9893c4e103, sha256 515447905c46270c25af1485a5cf527993fa90c48f1b81c900020f37122d20da)
BibTeX
@misc{dc6f9893c4e103,
  title = {Effects of Gestational Arsenic Exposures on Placental and Fetal Development in Mice: The Role of Cyr61 m6A — Europe PMC PMID:37682722},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/37682722},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_6f9893c4e103; sha256 515447905c46270c25af1485a5cf527993fa90c48f1b81c900020f37122d20da},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/37682722. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Background: Several epidemiological investigations demonstrated that maternal arsenic (As) exposure elevated risk of fetal growth restriction (FGR), but the mechanism remains unclear. Objectives: This study aimed to investigate the effects of gestational As exposure on placental and fetal development and its underlying mechanism. Methods: Dams were exposed to 0.15, 1.5, and 15mg/L NaAsO2 throughout pregnancy via drinking water. Sizes of fetuses and placentas, placental histopathology, and glycogen content were measured. Placental RNA sequencing was conducted. Human trophoblasts were exposed to NaAsO2 (2μM) to establish an in vitro model of As exposure. The mRNA stability and protein level of genes identified through RNA sequencing were measured. N6-Methyladenosine (m6A) modification was detected by methylated RNA immunoprecipitation-quantitative real-time polymerase chain reason (qPCR). The binding ability of insulin-like growth factor 2 binding protein 2 to the gene of interest was detected by RNA-binding protein immunoprecipitation-qPCR. Intracellular S-adenosylmethionine (SAM) and methyltransferase activity were determined by liquid chromatography-tandem mass spectrometry (LC-MS/MS) and colorimetry, respectively. In vitro As+3 methyltransferase (As3MT) knockdown or SAM supplementation and in vivo folic acid (FA) supplementation were used to evaluate the protective effect. A case-control study verified the findings. Results: Sizes of fetuses (exposed to 1.5 and 15mg/L NaAsO2) and placentas (exposed to 15mg/L NaAsO2) were lower in As-exposed mice. More glycogen+ trophoblasts accumulated and the expression of markers of interstitial invasion was lower in the 15mg/L NaAsO2-exposed mouse group in comparison with control. Placental RNA sequencing identified cysteine-rich angiogenic inducer 61 ( Cyr61 ) as a candidate gene of interest. Mechanistically, mice and cells exposed to As had lower protein expression of CYR61, and this was attributed to a lower incidence of Cyr61 m6A. Furthermore, cells exposed to As had lower methyltransferase activity, suggesting that this could be the mechanism by which Cyr61 m6A was affected. Depletion of intracellular SAM, a cofactor for m6A methyltransferase catalytic domain, partially contributed to As-induced methyltransferase activity reduction. Either As3MT knockdown or SAM supplementation attenuated As-induced Cyr61 m6A down-regulation. In mice, FA supplementation rescued As-induced defective trophoblastic invasion and FGR. In humans, a negative correlation between maternal urinary As and plasma CYR61 was observed in infants who were small for gestational age. Discussion: Using in vitro and in vivo models, we found that intracellular SAM depletion-mediated Cyr61 m6A down-regulation partially contributed to As-induced defective trophoblastic invasion and FGR. https://doi.org/10.1289/EHP12207.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera).
Pubblicazione: Environmental health perspectives, 2023 (prima pubblicazione 2023-09-08).
Identificativi: PMID 37682722 · PMCID PMC10489955 · DOI 10.1289/ehp12207.
Descrittori MeSH principali: Placenta; Arsenic.
Pagina: https://europepmc.org/article/MED/37682722 — https://doi.org/10.1289/ehp12207. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0.
Letto il 2026-10-07T11:59:26.214Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.